ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.71
-0.78%
US Tech 100
21,524.40
0.41%
S&P 500
6,114.63
-0.01%
US Dollar vs CAD
1.41895
0.01%
Bitcoin
97,596.47
0.08%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Schrodinger Inc (SDGR)

  7. Schrodinger Inc (SDGR) News

SDGR

Schrodinger (SDGR)

Schrodinger Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SDGR
DateTimeSourceHeadlineSymbolCompany
02/13/20253:01PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SDGRSchrodinger Inc
02/12/20253:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SDGRSchrodinger Inc
02/12/20253:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SDGRSchrodinger Inc
02/12/20257:30AMBusiness WireSchrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26NASDAQ:SDGRSchrodinger Inc
02/11/20255:34PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SDGRSchrodinger Inc
02/11/20253:15PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SDGRSchrodinger Inc
02/11/20253:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SDGRSchrodinger Inc
02/10/20254:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SDGRSchrodinger Inc
01/22/20257:30AMBusiness WireSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SDGRSchrodinger Inc
01/13/20256:00AMBusiness WireSchrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic PrioritiesNASDAQ:SDGRSchrodinger Inc
12/17/20247:30AMBusiness WireSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SDGRSchrodinger Inc
11/20/20247:30AMBusiness WireSchrödinger to Present at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
11/19/20247:30AMBusiness WireSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SDGRSchrodinger Inc
11/18/20247:30AMBusiness WireSchrödinger Broadens and Accelerates Predictive Toxicology InitiativeNASDAQ:SDGRSchrodinger Inc
11/13/20243:30PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SDGRSchrodinger Inc
11/12/20246:33AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SDGRSchrodinger Inc
11/12/20245:50AMBusiness WireSchrödinger Reports Third Quarter 2024 Financial ResultsNASDAQ:SDGRSchrodinger Inc
11/12/20245:45AMBusiness WireSchrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with NovartisNASDAQ:SDGRSchrodinger Inc
11/04/20247:30AMBusiness WireSchrödinger to Present at Jefferies London Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
10/31/20247:30AMBusiness WireSchrödinger to Announce Third Quarter 2024 Financial Results on November 12NASDAQ:SDGRSchrodinger Inc
10/23/20245:01AMBusiness WireSchrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR SymposiumNASDAQ:SDGRSchrodinger Inc
10/17/20247:30AMBusiness WireSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SDGRSchrodinger Inc
10/16/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SDGRSchrodinger Inc
10/15/20242:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SDGRSchrodinger Inc
10/09/20245:06AMBusiness WireSchrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR SymposiumNASDAQ:SDGRSchrodinger Inc
09/19/20241:18PMPR Newswire (US)Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law FirmNASDAQ:SDGRSchrodinger Inc
09/18/20247:30AMBusiness WireSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SDGRSchrodinger Inc
09/12/20243:32PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SDGRSchrodinger Inc
08/16/20247:30AMBusiness WireSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SDGRSchrodinger Inc
08/14/20247:30AMBusiness WireSchrödinger to Present at Morgan Stanley Global Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
 Showing the most relevant articles for your search:NASDAQ:SDGR

Your Recent History

USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
MVNT
Movement Industries (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
ERHE
ERHC Energy (CE)
NYSE
IONQ
IonQ
USOTC
AFFU
Affluence (PK)
NASDAQ
MGOL
MGO Global
NASDAQ
NB
NioCorp Developments
USOTC
MONI
Moon Equity (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
COIN
XRPUSD
Ripple
USOTC
ADIA
Adia Nutrition (PK)
USOTC
ASII
Accredited Solutions (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
CNNA
Cann American (CE)
USOTC
VPLM
Voip Pal Com (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads